Skip to main content
. 2020 Nov 9;4(21):5492–5500. doi: 10.1182/bloodadvances.2020003044

Table 1.

Participant demographics (N = 216)

Variables All patients
Age, mean (SD), y 53.7 (11.4)
Age, y
 <60 77 (35.7)
 ≥60 139 (64.3)
Sex
 Male 119 (55.1)
 Female 97 (44.9)
Race *
 White 196 (92.0)
 Nonwhite 17 (8.0)
Marital status
 Married 164 (76.3)
 Nonmarried 51 (23.7)
Working
 Yes 107 (49.8)
 No 108 (50.2)
Education
 Less than college graduate 89 (41.4)
 College graduate 64 (29.8)
 Postgraduate 62 (28.8)
Annual household income
 ≥$100 000 82 (41.4)
 >$100 000 116 (58.6)
CCI, mean (SD)§ 0.4 (0.9)
Cancer type
 Acute leukemia 40 (18.5)
 Lymphoma 85 (39.4)
 Other 91 (42.1)
MOS Social Support, mean (SD) 81.2 (13.8)

Unless otherwise noted, data are n (%).

MOS, Medical Outcomes Study.

*

Three patients had missing data.

One patient had missing data.

Eighteen patients had missing data.

§

Excluding a history of a hematologic malignancy.